Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 946064 | IM / LA |
no adverse event; dose #2 was given at wrong interval. Dose 2 administered 1 week after Dose 1 instead of 1 month apart
HTN, hyperlipidemia, prediabetes, obesity
Norvasc, Lipitor, Zepbound
nkda